AU2001290257A1 - Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same - Google Patents

Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same

Info

Publication number
AU2001290257A1
AU2001290257A1 AU2001290257A AU2001290257A AU2001290257A1 AU 2001290257 A1 AU2001290257 A1 AU 2001290257A1 AU 2001290257 A AU2001290257 A AU 2001290257A AU 2001290257 A AU2001290257 A AU 2001290257A AU 2001290257 A1 AU2001290257 A1 AU 2001290257A1
Authority
AU
Australia
Prior art keywords
same
compositions containing
medicinal compositions
glucopyranosyloxybenzylbenzene derivatives
glucopyranosyloxybenzylbenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001290257A
Other versions
AU2001290257A2 (en
AU2001290257B2 (en
Inventor
Hideki Fujikura
Nobuhiko Fushimi
Masayuki Isaji
Toshihiro Nishimura
Kazuya Tatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Priority claimed from PCT/JP2001/008239 external-priority patent/WO2002028872A1/en
Publication of AU2001290257A1 publication Critical patent/AU2001290257A1/en
Publication of AU2001290257A2 publication Critical patent/AU2001290257A2/en
Application granted granted Critical
Publication of AU2001290257B2 publication Critical patent/AU2001290257B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001290257A 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same Ceased AU2001290257B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-301523 2000-09-29
JP2000301523 2000-09-29
PCT/JP2001/008239 WO2002028872A1 (en) 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same

Publications (3)

Publication Number Publication Date
AU2001290257A1 true AU2001290257A1 (en) 2002-06-27
AU2001290257A2 AU2001290257A2 (en) 2003-05-01
AU2001290257B2 AU2001290257B2 (en) 2007-08-30

Family

ID=18783054

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9025701A Pending AU9025701A (en) 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containingthe same
AU2001290257A Ceased AU2001290257B2 (en) 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU9025701A Pending AU9025701A (en) 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containingthe same

Country Status (33)

Country Link
US (2) US6872706B2 (en)
EP (1) EP1329456B1 (en)
JP (1) JP3798375B2 (en)
KR (1) KR100647204B1 (en)
CN (1) CN1293087C (en)
AR (1) AR030816A1 (en)
AT (1) ATE335753T1 (en)
AU (2) AU9025701A (en)
BG (1) BG66015B1 (en)
BR (1) BR0114310A (en)
CA (1) CA2423568C (en)
CY (1) CY1106076T1 (en)
CZ (1) CZ303544B6 (en)
DE (1) DE60122193T2 (en)
DK (1) DK1329456T3 (en)
EA (1) EA005994B1 (en)
ES (1) ES2269456T3 (en)
HK (1) HK1061037A1 (en)
HU (1) HUP0301178A3 (en)
IL (2) IL155071A0 (en)
MX (1) MXPA03002779A (en)
MY (1) MY129023A (en)
NO (1) NO327182B1 (en)
NZ (1) NZ524917A (en)
PE (1) PE20020476A1 (en)
PL (1) PL205607B1 (en)
PT (1) PT1329456E (en)
SI (1) SI1329456T1 (en)
SK (1) SK287811B6 (en)
TW (1) TWI284641B (en)
UA (1) UA73606C2 (en)
WO (1) WO2002028872A1 (en)
ZA (1) ZA200302283B (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1020944C (en) 1990-01-30 1993-05-26 阿图尔-费希尔股份公司费希尔厂 Fastening element
EP1329456B1 (en) 2000-09-29 2006-08-09 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
JP4212891B2 (en) * 2000-11-30 2009-01-21 キッセイ薬品工業株式会社 Glucopyranosyloxybenzylbenzene derivative, pharmaceutical composition containing the same, and production intermediate thereof
TWI255817B (en) 2001-02-14 2006-06-01 Kissei Pharmaceutical Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1489089A4 (en) 2002-03-22 2009-10-28 Kissei Pharmaceutical Crystals of glucopyranosyloxybenzyl benzene derivative
PL372865A1 (en) * 2002-08-09 2005-08-08 Taisho Pharmaceutical Co, Ltd. Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same
JP4651934B2 (en) * 2002-12-04 2011-03-16 キッセイ薬品工業株式会社 Benzylphenol derivative, pharmaceutical composition containing it, and pharmaceutical use thereof
EP1568380A4 (en) * 2002-12-04 2009-10-21 Kissei Pharmaceutical Preventive or remedy for diseases caused by hyperglycemia
DE10258008B4 (en) * 2002-12-12 2006-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclic fluoroglycoside derivatives, medicaments containing these compounds and methods of making these medicaments
DE10258007B4 (en) 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatic fluoroglycoside derivatives, medicaments containing these compounds and methods for the preparation of these medicaments
UA86042C2 (en) * 2003-08-01 2009-03-25 Янссен Фармацевтика Н.В. Substituted indazole-o-glucosides
ES2387881T3 (en) 2004-03-16 2012-10-03 Boehringer Ingelheim International Gmbh Benzene derivatives substituted by glucopyranosyl, medicines containing these compounds, their use and procedure for their preparation
EP1731524A4 (en) * 2004-03-31 2009-05-20 Kissei Pharmaceutical Phenol derivative, medicinal composition containing the same, and medicinal use thereof
JP5010918B2 (en) * 2004-07-21 2012-08-29 キッセイ薬品工業株式会社 Inhibitors of disease progression caused by abnormal accumulation of liver fat
TW200606129A (en) 2004-07-26 2006-02-16 Chugai Pharmaceutical Co Ltd Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
US7687469B2 (en) * 2004-12-16 2010-03-30 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
JP5073948B2 (en) * 2005-01-31 2012-11-14 田辺三菱製薬株式会社 Pharmaceutical composition
EP1856082B1 (en) * 2005-02-23 2009-10-14 Boehringer Ingelheim International GmbH Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
WO2006108842A1 (en) * 2005-04-15 2006-10-19 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
UA91546C2 (en) 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Crystalline form of 1-chloro-4-(я-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
US7723309B2 (en) * 2005-05-03 2010-05-25 Boehringer Ingelheim International Gmbh Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
JP5128474B2 (en) * 2005-07-27 2013-01-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Glucopyranosyl-substituted ((hetero) cycloalkylethynyl-benzyl) -benzene derivatives, agents containing the compounds, their use and methods for their production
EP1924571B1 (en) * 2005-08-30 2010-10-13 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
CN101238112A (en) * 2005-09-08 2008-08-06 贝林格尔·英格海姆国际有限公司 Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
AR056195A1 (en) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int PROCEDURES TO PREPARE DERIVATIVES OF (ETINIL-BENCIL) -BENZENE REPLACED GLUCOPYRANOSIL AND INTERMEDIATE COMPOUNDS OF THE SAME
AU2007216452A1 (en) * 2006-02-15 2007-08-23 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
PE20080697A1 (en) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int BENZONITRILE DERIVATIVES SUBSTITUTED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, THEIR USE AND PROCEDURE FOR THEIR MANUFACTURE
PE20080251A1 (en) 2006-05-04 2008-04-25 Boehringer Ingelheim Int USES OF DPP IV INHIBITORS
DE102006028862A1 (en) 2006-06-23 2007-12-27 Merck Patent Gmbh 3-amino-imidazo [1,2-a] pyridine
TW200817424A (en) 2006-08-04 2008-04-16 Daiichi Sankyo Co Ltd Benzylphenyl glucopyranoside derivatives
US20080109178A1 (en) * 2006-11-03 2008-05-08 Nikon Corporation Method and system for predicting and correcting signal fluctuations of an interferometric measuring apparatus
MX2009005935A (en) 2006-12-06 2009-06-30 Smithkline Beecham Corp Chemical compounds and uses.
DE102007008420A1 (en) 2007-02-21 2008-08-28 Merck Patent Gmbh benzimidazole derivatives
CL2008002427A1 (en) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Pharmaceutical composition comprising 1-chloro-4- (bd-glucopyranos-1-yl) -2- [4 - ((s) -tetrahydrofuran-3-yloxy) benzyl] -benzene combined with 1 - [(4-methylquinazolin- 2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8- (3- (r) -aminopiperidin-1-yl) xanthine; and its use to treat type 2 diabetes mellitus.
DE102007048716A1 (en) 2007-10-11 2009-04-23 Merck Patent Gmbh Imidazo [1,2-a] pyrimidine derivatives
CL2008003653A1 (en) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Use of a glucopyranosyl-derived sglt inhibitor and a selected dppiv inhibitor to treat diabetes; and pharmaceutical composition.
WO2009096503A1 (en) * 2008-01-31 2009-08-06 Daiichi Sankyo Company, Limited Benzyl phenyl glucopyranoside derivative
DE102008017590A1 (en) 2008-04-07 2009-10-08 Merck Patent Gmbh Glucopyranosidderivate
WO2010009243A1 (en) 2008-07-15 2010-01-21 Theracos, Inc. Deuterated benzylbenzene derivatives and methods of use
ES2380408T3 (en) * 2008-08-28 2012-05-11 Pfizer Inc. Dioxa-bicyclo derivatives [3.2.1] octane-2,3,4-triol
BRPI1013638A2 (en) * 2009-02-13 2020-08-04 Boehringer Ingelheim International Gmbh pharmaceutical composition comprising glycopyranosyldiphenyl-methane derivatives, their pharmaceutical dosage form, process for their preparation, and their uses for better glycemic control in a patient
EP3711751A1 (en) 2009-02-13 2020-09-23 Boehringer Ingelheim International GmbH Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
EP2486029B1 (en) * 2009-09-30 2015-06-10 Boehringer Ingelheim International GmbH Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
WO2011039107A1 (en) * 2009-09-30 2011-04-07 Boehringer Ingelheim International Gmbh Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
US10610489B2 (en) * 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
US8394772B2 (en) 2009-10-20 2013-03-12 Novartis Ag Glycoside derivative and uses thereof
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
NZ599945A (en) 2009-11-02 2014-05-30 Pfizer Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2011070592A2 (en) 2009-12-09 2011-06-16 Panacea Biotec Ltd. Novel sugar derivatives
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
WO2012025857A1 (en) 2010-08-23 2012-03-01 Hetero Research Foundation Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
AR085689A1 (en) 2011-03-07 2013-10-23 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITIONS OF METFORMIN, LINAGLIPTINE AND AN SGLT-2 INHIBITOR
US8722633B2 (en) 2011-04-14 2014-05-13 Novartis Ag Glycoside derivatives and uses thereof
US8614195B2 (en) 2011-04-14 2013-12-24 Novartis Ag Glycoside derivatives and uses thereof
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
EP2774619B1 (en) 2013-03-04 2016-05-18 BioActive Food GmbH Composition for the treatment of hyperglycaemic diseases
ES2684399T3 (en) 2013-03-14 2018-10-02 Mars, Incorporated Aroma composition containing HMG glycosides
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
ES2702174T3 (en) 2013-04-05 2019-02-27 Boehringer Ingelheim Int Therapeutic uses of empagliflozin
MX2021004308A (en) 2013-04-18 2022-10-26 Boehringer Ingelheim Int Pharmaceutical composition, methods for treating and uses thereof.
EP2944311A1 (en) 2014-05-16 2015-11-18 BioActive Food GmbH Combination of biologically active substances for treating hyperglycemic diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549476B1 (en) * 1983-07-20 1986-04-25 Rech Ind BENZYL-PHENYL-OSIDES, PROCESS FOR PREPARATION AND THERAPEUTIC USE
US5731292A (en) * 1992-11-12 1998-03-24 Tanabe Seiyaku Co., Ltd. Dihydrochalcone derivatives which are hypoglycemic agents
CA2102591C (en) 1992-11-12 2000-12-26 Kenji Tsujihara Hypoglycemic agent
EP1270584B1 (en) * 2000-03-17 2005-12-07 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
US6683056B2 (en) * 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
EP1329456B1 (en) 2000-09-29 2006-08-09 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same

Similar Documents

Publication Publication Date Title
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL156558A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL156389A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL154817A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL145757A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL145756A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL151372A0 (en) Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL152846A0 (en) Pyridazinone derivatives and pharmaceutical compositions containing the same
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
AU2001274535A1 (en) Hydroxyformamidine derivatives and medicines containing the same
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU4543500A (en) Pharmaceutical compositions and uses
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001241117A1 (en) Fused-benzoyl derivatives and herbicide compositions containing the same
IL156032A0 (en) Spiroindene derivatives and pharmaceutical compositions containing the same